Hepatocellular Carcinoma and Viral Hepatitis in New York City

Clinical Infectious Diseases

Volumn 63, Issue 12, 2016, Pages 1577-1583

  Moore, Miranda S ^a,c   Ivanina, Elena ^a   Bornschlegel, Katherine ^a   Qiao, Baozhen ^b   Schymura, Maria J ^b   Laraque, Fabienne ^a,d  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NYC Department of Social Services   (United States)

Author keywords

hepatitis B; hepatitis C; hepatocellular carcinoma; screening; survival

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CAUSE OF DEATH; COINFECTION; CONTROLLED STUDY; FEMALE; HEPATECTOMY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ICD-9; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; NEW YORK; PACIFIC ISLANDER; RISK FACTOR; SURVIVAL TIME; VIRUS HEPATITIS; VIRUS LOAD; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; VIROLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; RISK ASSESSMENT;

EID: 85021933848     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw605     Document Type: Article

References (38)

1. Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973-2012), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. SEER Stat fact sheets: liver and intrahepatic bile duct cancer. Available at: http://seer.cancer.gov/statfacts/html/livibd.html. Accessed 14 May 2015.
2. American Cancer Society. Cancer facts & figures 2015. Atlanta, GA: American Cancer Society, 2015.
3. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014; 74:2913–21.
4. Surveillance, Epidemiology, and End Results Program, National Cancer Institute, National Institutes of Health. SEER*Stat databases: incidence—SEER 18 Regs research data + Hurricane Katrina impacted Louisiana cases, Nov 2014 Sub (1973-2012 varying). Available at: http://seer.cancer.gov/data/seerstat/nov2014/. Accessed 11 December 2015.
5. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118–27.
6. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142:1264–73. e1.
7. El-Serag HB. Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 2007; 37(Suppl2):S88–94.
8. Bruix J, Sherman M. AASLD practice guideline, management of hepatocellular carcinoma: an update. Available at: www.aasld.org/sites/default/files/guideline_documents/HCCUpdate2010.pdf. Accessed 25 July 2015.
9. New York State Cancer Registry. Cancer incidence and mortality in New York State, 1976-2012. Available at: http://www.health.ny.gov/statistics/cancer/registry/. Accessed 14 May 2015.
10. France AM, Bornschlegel K, Lazaroff J, Kennedy J, Balter S. Estimating the prevalence of chronic hepatitis B virus infection–New York City, 2008. J Urban Health 2012; 89:373–83.
11. Balter S, Stark JH, Kennedy J, Bornschlegel K, Konty K. Estimating the prevalence of hepatitis C infection in New York City using surveillance data. Epidemiol Infect 2014; 142:262–9.
12. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, eds. SEER summary staging manual—2000: codes and coding instructions. National Institutes of Health publication 01-4969. Bethesda, MD: National Cancer Institute, 2001.
13. Collaborative Stage Work Group of the American Joint Committee on Cancer. Collaborative Stage data collection system user documentation and coding instructions, version 02.03.02. Chicago, IL: American Joint Committee on Cancer, 2011.
14. United States Census Bureau. American Community Survey. Available at: http://www.census.gov/hhes/www/poverty/data/index.html. Accessed 27 September 2016.
15. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System. Hepatitis B, chronic. Available at: https://wwwn.cdc.gov/nndss/conditions/hepatitis-b-chronic/. Accessed 27 September 2016.
16. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System. Hepatitis C, past or present. Available at: https://wwwn.cdc.gov/nndss/conditions/hepatitis-c-chronic/. Accessed 19 September 2014.
17. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Registry Plus, a suite of publicly available software programs for collecting and processing cancer registry data, 2015. Available at: http://www.cdc.gov/cancer/npcr//index.htm. Accessed 11 December 2015.
18. Centers for Disease Control and Prevention. Premature mortality in the United States: public health issues in the use of years of potential life lost. MMWR Morb Mortal Wkly Rep 1986; 35(S2):1S–11.
19. Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol 2014; 28:753–70.
20. Blonski W, Kotlyar DS, Forde KA. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 2010; 16:3603–15.
21. Shebl FM, Capo-Ramos DE, Graubard BI, McGlynn KA, Altekruse SF. Socioeconomic status and hepatocellular carcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2012; 21:1330–5.
22. Zevin B. Managing chronic hepatitis C in primary-care settings: more than antiviral therapy. Public Health Rep 2007; 122(suppl 2):78–82.
23. Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Commun H 2006; 60:202–7.
24. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28:751.
25. AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Available at: http://hcvguidelines.org/sites/default/files/HCV-Guidance_April_2016_d1.pdf. Accessed 22 April 2016.
26. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016; 63:261–83.
27. Goldberg DS, Valderrama A, Kamalakar R, Sansgiry SS, Babajanyan S, Lewis JD. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B. J Viral Hepat 2015; 22:727–36.
28. Davila JA, Henderson L, Kramer JR, et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med 2011; 154:85–93.
29. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 2010; 52:132–41.
30. De Oliveria Andrade LJ, D’Oliveira A, Melo RC, De Souza EC, Costa Silva CA, Paraná R. Association Between Hepatitis C and Hepatocellular Carcinoma. J Global Infect Dis 2009; 1:33–7.
31. Wolf DC. Cirrhosis. Medscape website. Updated December 10, 2014. Available at: http://emedicine.medscape.com/article/185856-overview. Accessed 12 November 2015.
32. Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg 2007; 31:1243–8.
33. Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology 2012; 55:1652–61.
34. Ong P, Gambatese M, Begier E, Zimmerman R, Soto A, Madsen A. Effect of cause-of-death training on agreement between hospital discharge diagnoses and cause of death reported, inpatient hospital deaths, New York City, 2008-2010. Prev Chronic Dis 2015; 12:E04.
35. García-Samaniego J, Rodríguez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001; 96:179–83.
36. Pinchoff J, Drobnik A, Bornschlegel K, et al. Deaths among people with hepatitis C in New York City, 2000-2011. Clin Infect Dis 2014; 58:1047–54.
37. El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma: in whom and how? Therap Adv Gastroenterol 2011; 4:5–10.
38. Colombo M. Prevention of hepatocellular carcinoma and recommendations for surveillance in adults with chronic liver disease. Updated 7 April 2016. Available at: http://www.uptodate.com/contents/prevention-of-hepatocellular-carcinoma- and-recommendations-for-surveillance-in-adults-with-chronic-liver-disease. Accessed 14 July 2016.